Coverage positions published by the Dutch Healthcare Institute in December 2023

In December 2023, the Dutch Healthcare Institute (ZIN) published two coverage positions on high-intensity focused ultrasound (HIFU) in patients with essential tremor and radiotherapy with magnetic resonance linear accelerator (MR-linac).

In the Position on HIFU in patients with essential tremor, published on December 12, 2023, the ZIN concluded that it can be reimbursed under the basic health insurance in patients with moderate to severe essential tremor who do not respond adequately to medication and are not eligible for deep brain stimulation. The reimbursement will apply from August 5, 2022.

In the Position on MR-linac radiotherapy, published on November 28, 2023, the ZIN concluded that it cannot be reimbursed under the basic health insurance because there is no sufficient evidence to conclude that MR-linac complies with the “state of science and practice” criteria: MR-linac as a technical variant of existing radiotherapy methods has not demonstrated more precise treatment and fewer side effects.

See more information in Dutch here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.